Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 245152, 7 pages
http://dx.doi.org/10.1155/2013/245152
Research Article

Blood Glucose Control Using a Novel Continuous Blood Glucose Monitor and Repetitive Intravenous Insulin Boluses: Exploiting Natural Insulin Pulsatility as a Principle for a Future Artificial Pancreas

1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, MTFS, Postbox 8905, 7491 Trondheim, Norway
2Department of Anesthesiology and Intensive Care Medicine, Trondheim University Hospital, Postbox 3250 Sluppen, 7006 Trondheim, Norway
3Invivosense Norway Ltd., c/o NTNU Technology Transfer, Sem Saelands Vei 14, 7034 Trondheim, Norway
4Department of Electronics and Telecommunications, Faculty of Information Technology, Mathematics and Electrical Engineering, Norwegian University of Science and Technology, 7491 Trondheim, Norway
5Faculty of Technology, Sør-Trøndelag University College, Postbox 2320, 7004 Trondheim, Norway
6Department of Laboratory Medicine, Children’s and Women’s Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
7Department of Clinical Pharmacology, Trondheim University Hospital, Postbox 3250 Sluppen, 7006 Trondheim, Norway
8Unit of Comparative Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway

Received 13 August 2013; Accepted 24 October 2013

Academic Editor: Julia Mader

Copyright © 2013 Nils K. Skjaervold et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Friedrich, “Artificial pancreas may soon be a reality,” Journal of the American Medical Association, vol. 301, no. 15, pp. 1525–1527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Hovorka, “Continuous glucose monitoring and closed-loop systems,” Diabetic Medicine, vol. 23, no. 1, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. P. Kovatchev, E. Renard, C. Cobelli et al., “Feasibility of outpatient fully integrated closed-loop control first studies of wearable artificial pancreas,” Diabetes Care, vol. 36, no. 7, pp. 1851–1858, 2013. View at Google Scholar
  4. R. Hovorka, K. Kumareswaran, J. Harris et al., “Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomized controlled studies,” British Medical Journal, vol. 342, no. 7803, Article ID d1855, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. R. Murphy, D. Elleri, J. M. Allen et al., “Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes,” Diabetes Care, vol. 34, no. 2, pp. 406–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Cook, “Isolated islets of Langerhans have slow oscillations of electrical activity,” Metabolism, vol. 32, no. 7, pp. 681–685, 1983. View at Google Scholar · View at Scopus
  7. P. Bergsten, E. Grapengiesser, E. Gylfe, A. Tengholm, and B. Hellman, “Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets,” Journal of Biological Chemistry, vol. 269, no. 12, pp. 8749–8753, 1994. View at Google Scholar · View at Scopus
  8. M. Zhang, P. Goforth, R. Bertram, A. Sherman, and L. Satin, “The Ca2+ dynamics of isolated mouse β-cells and islets: implications for mathematical models,” Biophysical Journal, vol. 84, no. 5, pp. 2852–2870, 2003. View at Google Scholar · View at Scopus
  9. D. A. Lang, D. R. Matthews, J. Peto, and R. C. Turner, “Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings,” The New England Journal of Medicine, vol. 301, no. 19, pp. 1023–1027, 1979. View at Google Scholar · View at Scopus
  10. A. V. Matveyenko, J. D. Veldhuis, and P. C. Butler, “Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein,” The American Journal of Physiology, vol. 295, no. 3, pp. E569–E574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Pørksen, B. Nyholm, J. D. Veldhuis, P. C. Butler, and O. Schmitz, “In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts,” The American Journal of Physiology, vol. 273, no. 5, pp. E908–E914, 1997. View at Google Scholar · View at Scopus
  12. S. H. Song, S. S. McIntyre, H. Shah, J. D. Veldhuis, P. C. Hayes, and P. C. Butler, “Direct measurement of pulsatile insulin secretion from the portal vein in human subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4491–4499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Pørksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz, “Pulsatile insulin secretion: detection, regulation, and role in diabetes,” Diabetes, vol. 51, supplement 1, pp. S245–S254, 2002. View at Google Scholar · View at Scopus
  14. D. R. Matthews, B. A. Naylor, and R. G. Jones, “Pulsatile insulin has greater hypoglycemic effect than continuous delivery,” Diabetes, vol. 37, no. 7, pp. 617–621, 1983. View at Google Scholar · View at Scopus
  15. M. Komjati, P. Bratusch-Marrain, and W. Waldhausl, “Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro,” Endocrinology, vol. 118, no. 1, pp. 312–319, 1986. View at Google Scholar · View at Scopus
  16. T. T. Aoki, E. O. Grecu, M. A. Arcangeli, M. M. Benbarka, P. Prescott, and J. H. A. Jong Ho Ahn, “Chronic intermittent intravenous insulin therapy: a new frontier in diabetes therapy,” Diabetes Technology and Therapeutics, vol. 3, no. 1, pp. 111–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. G. E. Dailey, G. H. Boden, R. H. Creech et al., “Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy,” Metabolism, vol. 49, no. 11, pp. 1491–1495, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Reza Mirbolooki, G. E. Taylor, V. K. Knutzen, D. W. Scharp, R. Willcourt, and J. R. T. Lakey, “Pulsatile intravenous insulin therapy: the best practice to reverse diabetes complications?” Medical Hypotheses, vol. 73, no. 3, pp. 363–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Tierney, B. M. Hasle Falch, D. R. Hjelme, and B. T. Stokke, “Determination of glucose levels using a functionalized hydrogel-optical fiber biosensor: toward continuous monitoring of blood glucose in vivo,” Analytical Chemistry, vol. 81, no. 9, pp. 3630–3636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. K. Skjaervold, E. Solligård, D. R. Hjelme, and P. Aadahl, “Continuous measurement of blood glucose: validation of a new intravascular sensor,” Anesthesiology, vol. 114, no. 1, pp. 120–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. G. Chase, A. J. Le Compte, F. Suhaimi et al., “Tight glycemic control in critical care: the leading role of insulin sensitivity and patient variability: a review and model-based analysis,” Computer Methods and Programs in Biomedicine, vol. 102, no. 2, pp. 156–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. H. Kroll, “Biological variation of glucose and insulin includes a deterministic chaotic component,” BioSystems, vol. 50, no. 3, pp. 189–201, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. N. K. Skjaervold, O. Lyng, O. Spigset, and P. Aadahl, “Pharmacology of intravenous insulin administration: implications for future closed-loop glycemic control by the intravenous/intravenous route,” Diabetes Technology and Therapeutics, vol. 14, no. 1, pp. 23–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Hara, Y. J. Lin, X. Zhu et al., “Safe induction of diabetes by high-dose streptozotocin in pigs,” Pancreas, vol. 36, no. 1, pp. 31–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Hovorka, V. Canonico, L. J. Chassin et al., “Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes,” Physiological Measurement, vol. 25, no. 4, pp. 905–920, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Parker, F. J. Doyle III, and N. A. Peppas, “A model-based algorithm for blood glucose control in type I diabetic patients,” IEEE Transactions on Biomedical Engineering, vol. 46, no. 2, pp. 148–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Cobelli, E. Renard, and B. Kovatchev, “Artificial pancreas: past, present, future,” Diabetes, vol. 60, no. 11, pp. 2672–2682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Hovorka, “Closed-loop insulin delivery: from bench to clinical practice,” Nature Reviews Endocrinology, vol. 7, no. 7, pp. 385–395, 2011. View at Publisher · View at Google Scholar · View at Scopus